Clinical Lead

Trials

Studies that name Clinical Lead as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:13 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT07463196 · A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors

  AC Immune SA · recruiting · Healthy Participants, Obesity, Type 2 Diabetes Mellitus (T2DM) · study director
• Ph3
  NCT07265479 · A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

  Organon and Co · active not recruiting · Atopic Dermatitis · study director
• N/A
  NCT06991010 · Clinical Use Study of SAPH Device for Patent Hemostasis After a Transradial Procedure

  Transradial Technologies, LLC · not yet recruiting · Hemostasis of Arterial Punctures · study director
• Early Ph1
  NCT06891716 · [18F]ACI-19626 PET in TDP-43 Proteinopathies

  AC Immune SA · recruiting · Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), TDP-43 Proteinopathies · study director
• Ph2/Ph3
  NCT06295731 · Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

  Inhibrx Biosciences, Inc · recruiting · Head and Neck Squamous Cell Carcinoma (HNSCC), HPV Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) · study director
• N/A
  NCT05932238 · Systane® Hydration PF and Systane® Hydration Preserved

  Alcon Research · completed · Dry Eye · study director
• N/A
  NCT05932225 · Systane® Complete Preservative Free Lubricant Eye Drops

  Alcon Research · completed · Dry Eye · study director
• N/A
  NCT05902364 · Systane® Ultra Preservative Free Lubricant Eye Drops

  Alcon Research · completed · Dry Eye · study director
• N/A
  NCT05799950 · A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

  Alcon Research · completed · Aphakia · study director
• N/A
  NCT05796674 · Clareon IOL Retrospective Data Collection

  Alcon Research · completed · Aphakia, Astigmatism · study director
• Ph2
  NCT05560646 · A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

  Organon and Co · completed · Endometriosis · study director
• Ph2
  NCT05489211 · Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  AstraZeneca · recruiting · Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer · principal investigator
• Ph3
  NCT05172726 · Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

  Organon and Co · completed · Plaque Psoriasis · study director
• Ph2
  NCT04950075 · Study of INBRX-109 in Conventional Chondrosarcoma

  Inhibrx Biosciences, Inc · active not recruiting · Conventional Chondrosarcoma · study director
• Ph3
  NCT04626596 · A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)

  Organon and Co · completed · Contraception · study director
• Ph1/Ph2
  NCT04198766 · Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  Inhibrx Biosciences, Inc · recruiting · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer · study director
• Ph1
  NCT03809624 · Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

  Inhibrx Biosciences, Inc · terminated · Metastatic Solid Tumors, Non-small Cell Lung Cancer, Melanoma · study director
• Ph1
  NCT03715933 · Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  Inhibrx Biosciences, Inc · recruiting · Ewing Sarcoma, Colorectal Adenocarcinoma · study director
• Ph1
  NCT03260491 · U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer

  Daiichi Sankyo · active not recruiting · Non-Small Cell Lung Cancer (NSCLC) · study director
• N/A
  NCT00903110 · Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

  Esteve Pharmaceuticals, S.A. · recruiting · IGF1 Deficiency · study director
• Ph3
  NCT00890097 · Geographic Atrophy Treatment Evaluation

  Alcon Research · terminated · Geographic Atrophy, Age-Related Macular Degeneration · study director
• Ph1
  NCT00408434 · Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer

  Daiichi Sankyo · completed · Neoplasm · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.